Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intestinal Microbiota Interventions to Enhance Athletic Performance-A Review.

International journal of molecular sciences·2024
Same author

A Systematic Review of the Design, Method of Implantation and Early Clinical Outcomes of Transcatheter Tricuspid Prostheses.

Reviews in cardiovascular medicine·2024
Same author

Impact of vaccination on COVID-19 severity during the second wave in Brunei Darussalam, 2021.

Western Pacific surveillance and response journal : WPSAR·2024
Same author

Characteristics of Children with Newly Diagnosed Type 1 Diabetes Mellitus in Brunei Darussalam.

Journal of the ASEAN Federation of Endocrine Societies·2023
Same author

COVID-19 and <i>Mycobacterium</i> coinfection in Brunei Darussalam: case series.

Western Pacific surveillance and response journal : WPSAR·2023
Same author

A swallowable X-ray dosimeter for the real-time monitoring of radiotherapy.

Nature biomedical engineering·2023

Related Experiment Video

Updated: Jul 17, 2026

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)

Published on: April 24, 2017

Surgical coronary revascularization in severe left ventricular dysfunction.

Chee Fui Chong1, Ali Akbar Fazuludeen, Christie Tan

  • 1Department of Cardiac, Thoracic and Vascular Surgery, National University Hospital, 5 Lower Kent Ridge Road, 119074 Singapore. chong_chee_fui@hotmail.com

Asian Cardiovascular & Thoracic Annals
|January 25, 2007
PubMed
Summary

Surgical revascularization is a safe option for patients with severe left ventricular dysfunction, showing acceptable mortality and improved heart function post-surgery. This procedure offers benefits for high-risk cardiac patients.

More Related Videos

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Left Coronary Artery Ligation: A Surgical Murine Model of Myocardial Infarction
05:48

Left Coronary Artery Ligation: A Surgical Murine Model of Myocardial Infarction

Published on: August 9, 2022

Related Experiment Videos

Last Updated: Jul 17, 2026

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)

Published on: April 24, 2017

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Left Coronary Artery Ligation: A Surgical Murine Model of Myocardial Infarction
05:48

Left Coronary Artery Ligation: A Surgical Murine Model of Myocardial Infarction

Published on: August 9, 2022

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Research

Background:

  • Coronary artery disease (CAD) with severe left ventricular dysfunction presents significant surgical challenges.
  • Surgical revascularization is a common intervention for these complex cases.

Purpose of the Study:

  • To evaluate the safety and outcomes of surgical revascularization in high-risk patients with severe left ventricular dysfunction.

Main Methods:

  • A cohort of 50 patients with severe left ventricular dysfunction (mean ejection fraction 19.7%) underwent surgical revascularization between September 2002 and May 2004.
  • Data collected included patient demographics, EuroSCORE, surgical indications, graft numbers, and postoperative support requirements.
  • Morbidity, postoperative cardiac function improvement, and 30-day mortality were assessed.

Main Results:

  • The study included 50 high-risk patients (mean age 59) with indications including heart failure, angina, and left main stem disease.
  • Postoperative support was frequently required, with 34% needing intra-aortic balloon pumps and 96% inotropic support.
  • Morbidity included renal failure (10%) and fatal multiorgan failure (4%), with a 30-day hospital mortality of 8%.

Conclusions:

  • Surgical revascularization can be performed with acceptable hospital mortality in patients with severe left ventricular dysfunction.
  • A significant proportion of patients (61%) demonstrated improved left ventricular function post-surgery.
  • The findings support surgical revascularization as a viable option for carefully selected high-risk cardiac patients.